FDA Approves Merck Tumor Treatment for DNA-Linked Cancers

In a move towards general cancer treatment, the FDA has approved Merck’s cancer drug for the treatment of any advanced tumor with microsatellite instability or DNA mismatch repair defects. Variants of these DNA indicators are present in genetically-linked cancers. The...

Bayer Granted Fast Track Approval from FDA for Cancer Drug

Bayer Pharmaceuticals announced this week that its cancer drug, Copanlisib, has been granted priority review by the FDA. The expedited process means that Bayer will know within 6 months whether Copanlisib has been granted regulatory approval versus the standard 10...